Many immunotherapies rely on the presence of neoepitopes derived from somatic mutations that lead to altered peptide sequences. Several studies have now analyzed the neoepitope landscape of different cancer subtypes, predominantly for adult samples, which tend to feature significantly higher mutational burden. However, a new report publishing the first comprehensive analysis of the pediatric neoepitope landscape suggests that immunotherapies could also hold promise for pediatric cancers. See related research article 10.1186/s13073-017-0468-3

Original languageEnglish
Article number77
JournalGenome medicine
Issue number1
StatePublished - Aug 31 2017


  • Exome sequencing
  • Immunotherapy
  • Neoepitope
  • Personalized cancer vaccine
  • RNA sequencing
  • Whole-genome sequencing


Dive into the research topics of 'Clinical implications of neoepitope landscapes for adult and pediatric cancers'. Together they form a unique fingerprint.

Cite this